Table 4.
Association of serum lipids with diabetic retinopathy from various studies in Chinese diabetic population
| Study/reference | Number of diabetic patients | Outcome | Serum lipid |
||||
| TC | TG | HDLC | LDLC | VLDLC | |||
| Beijing eye study (Wang S. et al., 2012) | 235 | DR | − | − | +/− | − | NA |
| Handan eye study (Wang F.H. et al., 2011) | 368 | DR | +/− | − | − | +/− | NA |
| Beijing community diabetes study (Xu et al., 2012) | 2 007 | DR PDR | + | − | − | + | NA |
| PDR | − | − | − | − | NA | ||
| Beijing 301 Hospital study (Liu et al., 2002) | 2 131 | DR | +/− | − | NA | NA | NA |
| Peking University People’s Hospital study (Cai et al., 2006) | 746 | DR | + | − | + | − | NA |
| PDR | − | − | − | − | NA | ||
| Shanghai diabetic complications study (Pang et al., 2012) | 799 | DR | − | − | − | − | NA |
| Current study | 523 | DR | + | + | − | − | + |
| PDR | − | − | − | − | − | ||
−: no statistically significant association; +: statistically significant association; +/−: marginally significance was dependent on how data were analyzed and presented. DR: diabetic retinopathy; PDR: proliferative diabetic retinopathy; TC: total cholesterol; TG: triglyceride; HDLC: high density lipoprotein cholesterol; LDLC: low density lipoprotein cholesterol; VLDLC: very low density lipoprotein cholesterol; NA: not available